(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TERAPIA IMUNO-ONCOLÓGICA USANDO COMPOSTOS ISOFLAVONA

ArquivadaInvention PatentPCT · AU2020050730

Application data

Number

112021026559

Type

Invention Patent

Filing

07/16/2020

Publication

02/15/2022

PCT

AU2020050730

Progress at the INPI

  1. Filing07/16/20
  2. Publication02/15/22
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 07/16/2020 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/24/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

NOXOPHARM LIMITED

AU

Inventors

G. K. (pessoa física)

AU

O. L. (pessoa física)

AU

Technical data

Priority claims

AU

2019902518 · 07/17/2019

Abstract

TERAPIA IMUNO-ONCOLÓGICA USANDO COMPOSTOS ISOFLAVONA. Um método para melhorar uma resposta em um indivíduo à terapia imuno-oncológica contra câncer, como um inibidor de ponto de verificação, usando um composto isoflavona de fórmula I.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

10/24/2023

RPI 2755

Arquivamento - Art. 33 da LPI

#11.1

08/08/2023

RPI 2744

Notificação de entrada na fase nacional - PCT

#1.3

02/15/2022

RPI 2667

Alteração de dados cadastrais

#1.1

01/11/2022

RPI 2662

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.